Profile data is unavailable for this security.
About the company
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.
- Revenue in CAD (TTM)0.00
- Net income in CAD-2.67m
- Incorporated1980
- Employees--
- LocationCVR Medical Corp4664 Sierra View DriveDENVER 28037United StatesUSA
- Phone+1 (734) 718-5115
- Fax+1 (604) 669-0774
- Websitehttp://cvrmed.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Waverley Pharma Inc | 144.82k | -2.25m | 1.35m | -- | -- | -- | -- | 9.32 | -0.0417 | -0.0417 | 0.0027 | -0.0323 | 0.0984 | 2.22 | 2.38 | -- | -153.02 | -32.30 | -- | -60.75 | -16.68 | 13.74 | -1,555.37 | -94.30 | 0.0995 | -9.94 | 8.80 | -- | -66.95 | 13.03 | -234.91 | -- | -- | -- |
Vaxil Bio Ltd | 0.00 | -110.00k | 1.37m | -- | -- | 1.74 | -- | -- | -0.0008 | -0.0008 | 0.00 | 0.0058 | 0.00 | -- | -- | -- | -10.99 | -65.45 | -13.02 | -116.22 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 56.51 | -- | -- | -- |
CVR Medical Corp | 0.00 | -2.67m | 1.99m | -- | -- | -- | -- | -- | -0.0259 | -0.0259 | 0.00 | -0.0609 | 0.00 | -- | -- | -- | -322.06 | -341.11 | -- | -- | -- | -- | -- | -- | -- | -2.46 | -- | -- | -- | -- | -948.22 | -- | -- | -- |